Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Procedural Outcomes and Safety of Cerebral Embolic Protection Device for Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement in Routine Clinical Practice, A Multicenter, Prospective Observational Study

NCT05217888 is registered in ClinicalTrials.gov with Duk-Woo Park, MD as lead sponsor.

NCT NCT05217888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05217888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Procedural Outcomes and Safety of Cerebral Embolic Protection Device for Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement in Routine Clinical Practice, A Multicenter, Prospective Observational Study
Lead sponsor
Duk-Woo Park, MD
Phase
Observational
Overall status
Completed
Start date
May 18, 2022
Completion date
May 20, 2025
Enrollment
158 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve disease, transcatheter aortic valve implantation, transcatheter aortic valve replacement